Incidence and cost of bleeding events requiring hospitalization in patients with atrial fibrillation treated with acenocoumarol in Greece

Incidence and cost of bleeding events requiring hospitalization in patients with atrial fibrillation treated with acenocoumarol in Greece

Background: To estimate the incidence of hemorrhagic events in patients with atrial fibrillation (AF) treated with acenocoumarol, and the management cost of those requiring hospitalization in Greece. Methods: A nationwide telephone survey was conducted between December 2017 and January 2018, to iden...

Full description

Bibliographic Details
Main Authors:	Georgia Kourlaba, Garyfallia Stefanou, Sotiris Tsalamandris, Evangelos Oikonomou, Giannis Papageorgiou, Nikos Nikas, Dimitris Tousoulis, Nikos Maniadakis
Format:	Article
Language:	English
Published:	Elsevier 2021-05-01
Series:	Hellenic Journal of Cardiology
Subjects:	Atrial fibrillation Hemorrhage Incidence Cost Acenocoumarol
Online Access:	http://www.sciencedirect.com/science/article/pii/S1109966620301597

Similar Items

Interaction of food supplement L-carnitine with oral anticoagulant acenocoumarol
by: HU Bachmann
Published: (2004-06-01)

Healthcare resources and costs associated with nonvalvular atrial fibrillation in Spain: apixaban versus acenocoumarol
by: Josep Comin Colet, et al.
Published: (2023-07-01)

Efficiency and effectiveness of the use of an acenocoumarol pharmacogenetic dosing algorithm versus usual care in patients with venous thromboembolic disease initiating oral anticoagulation: study protocol for a randomized controlled trial
by: Carcas Antonio J, et al.
Published: (2012-12-01)

Better stability of acenocoumarol compared to warfarin treatment in one-year observational, clinical study in patients with nonvalvular atrial fibrillation
by: Lejla Burnazović-Ristić, et al.
Published: (2011-02-01)

A Pharmacogenetically Guided Acenocoumarol Dosing Algorithm for Chilean Patients: A Discovery Cohort Study
by: Angela Roco, et al.
Published: (2020-04-01)

Acenocoumarol Pharmacogenetic Dosing Algorithm versus Usual Care in Patients with Venous Thromboembolism: A Randomised Clinical Trial
by: Hoi Yan Tong, et al.
Published: (2021-06-01)

Successful outcome with outpatient acenocoumarol therapy for echocardiographically visible pulmonary thrombus
by: Karanam Gowrinath, et al.
Published: (2021-01-01)

OPINION SURVEY OF THE CARDIOLOGISTS IN BULGARIA REGARDING THERAPY WITH ACETYLSALICYLIC ACID, CLOPIDOGREL AND ACENOCOUMAROL IN PATIENTS UNDERGOING DENTAL EXTRACTIONS
by: Atanaska Dinkova, et al.
Published: (2017-10-01)

OPINION SURVEY OF THE GENERAL PRACTITIONERS IN BULGARIA REGARDING THERAPY WITH ACETYLSALICYLIC ACID, CLOPIDOGREL AND ACENOCOUMAROL IN PATIENTS UNDERGOING DENTAL EXTRACTIONS
by: Atanaska Dinkova, et al.
Published: (2017-11-01)

Acenocoumarol, an Anticoagulant Drug, Prevents Melanogenesis in B16F10 Melanoma Cells
by: Hyunju Han, et al.
Published: (2023-04-01)

Comparison of Anticoagulation Quality between Acenocoumarol and Warfarin in Patients with Mechanical Prosthetic Heart Valves: Insights from the Nationwide PLECTRUM Study
by: Danilo Menichelli, et al.
Published: (2021-03-01)

The Association Between Long-Term Acenocoumarol Treatment and Vitamin D Deficiency
by: Jolanta Sawicka-Powierza, et al.
Published: (2018-05-01)

Acenocoumarol Exerts Anti-Inflammatory Activity via the Suppression of NF-κB and MAPK Pathways in RAW 264.7 Cells
by: Hyun-Ju Han, et al.
Published: (2023-02-01)

The VKORC1 and CYP2C9 gene variants as pharmacogenetic factors in acenocoumarol therapy in Serbian patients - consideration of hypersensitivity and resistance
by: Rakićević Ljiljana, et al.
Published: (2022-01-01)

Genotype-phenotype correlations in patients treated with acenocoumarol / Corelaţii genotip-fenotip la pacienţii trataţi cu acenocumarol
by: Militaru Florentina Claudia, et al.
Published: (2014-09-01)

Self-reported prevalence of atherothrombosis in a general population sample of adults in Greece; A telephone survey
by: Fragoulakis Vasileios, et al.
Published: (2011-04-01)

Bosentan and oral anticoagulants in HIV patients: what we can learn of cases reported so far
by: José Antonio Morales-Molina, et al.
Published: (2011-10-01)

Mortality Rate in Upper Gastrointestinal Bleeding Associated with Anti-Thrombotic Therapy Before and During Covid-19 Pandemic
by: Popa P, et al.
Published: (2022-11-01)

Is the time in therapeutic range on coumarins predicted by previous time in therapeutic range?
by: Jasper H. A. vanMiert, et al.
Published: (2020-05-01)

Burden of Atopic Dermatitis in Adults in Greece: Results from a Nationwide Survey
by: Stamatis Gregoriou, et al.
Published: (2022-08-01)

Clinical Impact of the Time in Therapeutic Range on Early Hospital Readmission in Patients with Acute Heart Failure Treated with Oral Anticoagulation in Internal Medicine
by: Rubén Ángel Martín-Sánchez, et al.
Published: (2021-04-01)

The disease burden of chronic obstructive pulmonary disease in Greece
by: Kourlaba G, et al.
Published: (2016-09-01)

Economic evaluation of statins in high-risk patients treated for primary and secondary prevention of cardiovascular disease in Greece
by: Fragoulakis V, et al.
Published: (2012-05-01)

Economic evaluation of intravenous iron treatments in the management of anemia patients in Greece
by: Fragoulakis V, et al.
Published: (2012-05-01)

Health literacy of patients on oral anticoagulation treatment- individual and social determinants and effect on health and treatment outcomes
by: Ana Cristina Cabellos-García, et al.
Published: (2021-07-01)

The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives
by: Sotirios Tsalamandris, et al.
Published: (2019-01-01)

Increasing Incidence of Zoonotic Visceral Leishmaniasis on Crete, Greece
by: Maria Antoniou, et al.
Published: (2009-06-01)

Efficiency of treatment by acenocoumarol in patients with permanent form of atrial fibrillation, with using models of personalized medicine
by: I V Kukes, et al.
Published: (2009-12-01)

The role of interleukin-6 genetic variant on inflammation and endothelial function in patients with unstable angina
by: Sotirios Tsalamandris, et al.
Published: (2022-01-01)

Atrial Fibrillation: Pathogenesis, Predisposing Factors, and Genetics
by: Marios Sagris, et al.
Published: (2021-12-01)

SAFETY OF TEETH EXTRACTIONS IN PATIENTS ON ACENOCOUMAROL THERAPY
by: Atanaska Dinkova, et al.
Published: (2020-04-01)

Percutaneous Treatment Approaches in Atrial Fibrillation: Current Landscape and Future Perspectives
by: Panagiotis Theofilis, et al.
Published: (2022-09-01)

Efficacy of a joint didactic intervention using the Junta De Andalucía School for Patients method to control prothrombin time in patients taking anticoagulants: protocol for a randomized controlled trial
by: Leovigildo Ginel-Mendoza, et al.
Published: (2021-01-01)

Relationship between whole grain consumption and arterial stiffness. Results of the Corinthia cross-sectional study
by: Georgia Vavouranaki, et al.
Published: (2021-05-01)

Protective Effect of Pretreatment with Acenocoumarol in Cerulein-Induced Acute Pancreatitis
by: Zygmunt Warzecha, et al.
Published: (2016-10-01)

Factors influencing prescribing behaviour of physicians in Greece and Cyprus: results from a questionnaire based survey
by: Fragoulakis Vasilis, et al.
Published: (2009-08-01)

Translation and validation of patient-oriented eczema measure in the Greek language
by: Garyfallia Stefanou, et al.
Published: (2023-10-01)

Time trends for pulmonary embolism incidence in Greece
by: Dimitrios G. Raptis, et al.
Published: (2020-01-01)

Effects of benchmarking on the quality of type 2 diabetes care: results of the OPTIMISE (Optimal Type 2 Diabetes Management Including Benchmarking and Standard Treatment) study in Greece
by: Vasilis Tsimihodimos, et al.
Published: (2015-10-01)

Relationships between Urban Form and Travel Behaviour in Athens, Greece. A Comparison with Western European and North American Results
by: Dimitris Milakis, et al.
Published: (2008-06-01)